Coronavirus disease 2019 (COVID-19) continues to spread globally, although early-hit nations are finally seeing flattening of their incidence curves from mitigation strategies. Age, comorbidity, and male sex seem
to be risk factors for poor outcomes but questions remain about optimal critical care management, effective treatment, and relaxation of mitigation strategies.
Browse the JAMA Network COVID-19 collection below, including Q&A's with NIAID's Anthony Fauci, an
interactive map of the outbreak courtesy of The Johns Hopkins Center for Systems Science and Engineering, and past publications on vaccine development, infection
control, and public health preparedness.
JAMA Editor Howard Bauchner interviews guests about the latest developments in the global coronavirus outbreak. Watch for updates on COVID-19 diagnosis and treatment.
What your doctors are listening to: conversations with frontline clinicians and experts on the frontiers of the global COVID-19 pandemic, hosted by JAMA Network Editor in Chief Howard
Bauchner, MD and specialist editors.
It is too early to predict how widespread and pathogenic 2019-nCoV will become. It is better to act decisively now rather than wait to see how the outbreak unfolds globally. Beyond all,
this global health threat teaches, once again, that it is far better to invest in preparedness to prevent, rapidly identify, and contain outbreaks at their source. Reacting after a novel
infection has spread widely (perhaps overreacting with travel bans and quarantines) costs lives, economic resources, and the well-being of millions of people currently cordoned off in a
zone of contagion.
Hardening the border and restricting travel and immigration will not stop pathogenic threats. The best protection of US residents is to stop threats at their origin, while supporting the
The United States must reassert its global leadership. Now is a pivotal moment to strengthen health security, from providing robust support for the GHSA and the Rapid Response Fund, to
funding new vaccines and antimicrobials. The path ahead is clear, but the political will is very much in question.
Emerging viral diseases with pandemic potential are a perpetual challenge to global health. The time-honored approach to vaccinology, which depends predominantly on isolating and growing
the pathogen, has not adequately met this challenge. To effectively prepare for and respond to these continually emerging threats, it will be critical to exploit modern-day technological
advances, preemptively establish detailed information on each family of viral pathogens, and invest in more infrastructure for surveillance in developing countries to expedite pathogen
identification and jump-start the process of vaccine development using these new technologies. Failure to do so will result in the untenable situation of not optimally using vaccinology in
the response to newly emerging infectious disease threats.
The Johns Hopkins Center for Systems Science and Engineering has developed an online dashboard to visualize and track reported COVID-19 cases on a daily timescale; the complete set of data
is downloadable as a google sheet.
The CDC website is updated regularly to reflect the latest U.S. coronavirus statistics and recommendations for managing the pandemic.
The WHO website is updated regularly to reflect the latest news, global statistics, and technical guidance for managing the pandemic.
You currently have no searches saved.
You currently have no courses saved.